Influence of nitric oxide donors and of the alpha(2)-agonist UK-14,304 on acetylcholine release in the pig gastric fundus

Neuropharmacology. 2001;40(2):270-8. doi: 10.1016/s0028-3908(00)00123-4.

Abstract

This study in circular muscle strips of the pig gastric fundus aimed to measure the release of acetylcholine directly and to investigate whether NO and alpha(2)-adrenoceptor agonists can modulate acetylcholine release from cholinergic neurones. After incubation of the tissues with [(3)H]-choline, basal and electrically induced release of tritium and [(3)H]-acetylcholine were analyzed in a medium containing physostigmine (10(-5) M) as well as atropine (10(-6) M). The NO synthase inhibitor L-N(G)-nitroarginine methyl ester (3x10(-4) M), and the NO donors sodium nitroprusside (10(-5) M) and 3-morpholino-sydnonimine (10(-5) M) did not influence the basal release nor the electrically evoked release, indicating that NO does not modify [(3)H]-acetylcholine release. The alpha(2)-adrenoceptor agonist UK-14,304 (10(-5) M) significantly inhibited the electrically evoked release of [(3)H]-acetylcholine, and this effect was prevented by the alpha(2)-adrenoceptor antagonist rauwolscine (2x10(-6) M), suggesting that presynaptic alpha(2)-adrenoceptors are present on cholinergic neurones of the pig gastric fundus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / metabolism*
  • Adrenergic alpha-Agonists / pharmacology*
  • Animals
  • Brimonidine Tartrate
  • Chromatography, High Pressure Liquid
  • Enzyme Inhibitors / pharmacology
  • Gastric Fundus / metabolism*
  • In Vitro Techniques
  • Nitric Oxide Donors / pharmacology*
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Quinoxalines / pharmacology*
  • Receptors, Adrenergic, alpha-2 / drug effects*
  • Swine

Substances

  • Adrenergic alpha-Agonists
  • Enzyme Inhibitors
  • Nitric Oxide Donors
  • Quinoxalines
  • Receptors, Adrenergic, alpha-2
  • Brimonidine Tartrate
  • Nitric Oxide Synthase
  • Acetylcholine